Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs RxPros

Mevo Health
Graded #326

Lower grade

vs+9.099999999999994
RxPros
Graded #128

Higher grade

The verdict

RxPros takes it — 69.3/100 to 60.2/100.

RxPros grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxPros (rxpros.com) is a Wyoming-incorporated compounded GLP-1 telehealth platform (RxPros LLC, 1309 Coffeen Ave Ste 15880, Sheridan, WY 82801).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxPros +15
56
71
Dose & formulationMevo Health +19
83
64
Clinical oversightRxPros +24
67
91
Labs & monitoringRxPros +1
52
53
FulfillmentRxPros +17
57
74
Contract termsRxPros +27
20
47
Mevo Health · left barRxPros · right bar

The numbers

MetricMevo HealthRxPros
WeighScore60.2/10069.3/100
GradeCC
Scorecard rank#326#128
Semaglutide$199/mo (all doses, compounded)$100/mo (annual plan, compounded)
Tirzepatide$259/mo (all doses, compounded)$145/mo (annual plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
RxPros

Graded #128 · C

Strengths

  • $99.99/month compounded semaglutide — among the cheapest in the US compounded telehealth market
  • $144.97/month compounded tirzepatide — at the lower end of the compounded tirzepatide range
  • LegitScript Certified
  • Named legal entity (RxPros LLC) with a physical Wyoming address
  • Overnight cold-packed shipping disclosed — important for GLP-1 cold-chain integrity

Where it loses points

  • Per-state availability not listed — verify your state ships before committing
  • Specific 503A pharmacy partners not named
  • Lab work not included as standard
  • LegitScript certification number not displayed (seal only)
  • Lowest headline prices ($99.99 sema / $144.97 tirz) require annual prepay; intro-first-month/quarterly tier is $134.99 sema / $224.99 tirz

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard